Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$5.32B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 2.94%
Avg Daily Range (30 D):	$2.21 | 2.03%
Avg Daily Range (90 D):	$2.22 | 2.25%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.62M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	889
Avg Institutional Trade:	$3.82M
Avg Institutional Trade (30 D):	$8.05M
Avg Institutional Trade (90 D):	$7.1M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$6.26M
Avg Closing Trade (30 D):	$8.97M
Avg Closing Trade (90 D):	$10.63M
Avg Closing Volume:	121.39K

News

Mar 9, 2026 @ 9:42 PM Celcuity Announces Publication of Results from PIK... Source: Celcuity Inc.

Feb 22, 2026 @ 7:05 PM Celcuity Stock Soars 700% in a Year as One Investo... Source: Jonathan Ponciano

Feb 13, 2026 @ 12:34 PM Soleus Adds a Significant Number of Celcuity Share... Source: Lawrence Rothman, Cfa

Feb 6, 2026 @ 9:05 PM Director Sells 20,000 Celcuity Shares for $2.4 Mil... Source: Sarah Sidlow

Dec 4, 2025 @ 9:47 AM 3 Stocks You’ll Wish You Bought Before 2026... Source: Chris Markoch

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.69	$-.92	$-1.04
Diluted EPS	$-3.69	$-.92	$-1.04
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-162.72M	$-43.8M	$-45.27M
Operating Income / Loss	$-159.42M	$-42.85M	$-44.01M
Cost of Revenue
Net Cash Flow	$61.65M	$27.9M	$29.88M
PE Ratio